ClinicalTrials.gg
RecruitingNCT05520593Updated Apr 13, 2026

Preoperative Oral Hydration in the Ambulatory Arthroplasty Population

An interventional study of Complex Carbohydrate Drink in Same-day Discharge and Length of Stay, sponsored by Hospital for Special Surgery, New York. Recruiting at 1 site in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-13.

Sponsored by Hospital for Special Surgery, New York · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Nov 2022; still recruiting 4 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
312
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The purpose of this study is to investigate if the consumption of a complex carbohydrate drink preoperatively, decreases the length of stay and causes for failure to launch in patients undergoing ambulatory total joint arthroplasty.

Read the detailed description

The way total joint arthroplasty is practiced continues to evolve as CMS removed total hip arthroplasty (THA) from the inpatient-only list and added total knee arthroplasty (TKA) to the ASC Covered Surgical Procedures List (CPL) in 2020. Thus, surgeons must find subtle interventions that improve patient outcomes while minimizing the risk of adverse reactions. Current literature has not assessed the influence of preoperative hydration, using a complex carbohydrate drink, on the same-day discharge rate and causes for failure to launch. Considering variabilities in perioperative fluid management leading to postoperative nausea, vomiting, and dizziness, the investigators seek to reduce the incidence of these events by optimizing patients using a preoperative oral hydration protocol, reducing the length of stay, and improving same-day discharge rates.

02

Conditions studied

  • Same-day Discharge
  • Length of Stay

Browse trials for

Keywords

  • Carbohydrate Drink
  • Perioperative Fluids
  • Same-day Discharge
  • Total Joint Arthroplasty
  • Nausea
  • Vomiting
  • Same-day total hip arthroplasty
  • Same-day total knee arthroplasty
03

In context

Nausea

644 studies on the registry are indexed under Nausea; 85 are open to participants now.

This study's planned enrollment of 312 is above the median of 96 across 544 interventional studies indexed under Nausea.

Browse Nausea studies →

Lead sponsor

Hospital for Special Surgery, New York is the lead sponsor of 226 studies on the registry; 40 are open to participants now.

Of its 30 completed or terminated interventional studies of FDA-regulated products, 22 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Candidates for ambulatory total knee arthroplasty
  • Candidates for ambulatory total hip arthroplasty
  • Candidates for ambulatory revision knee arthroplasty (liner exchange only)
  • Candidates for ambulatory revision hip arthroplasty (liner exchange only)
  • Case scheduled before noon (12 pm)
  • Patient agrees to same-day discharge and has a responsible adult to spend the night on the day of discharge

Exclusion criteria

Exclusion Criteria:

  • less than 18.5 or greater than 37.0
  • Patients with diabetes, chronic kidney disease, clotting disorders, or neurological conditions preventing control of the affected limb.
  • Pregnant women
  • Patients scheduled as ambulatory due to insurance mandates
  • Patients with a history of active ischemia, significant valvular disease, significant arrhythmias, obstructive sleep apnea as per Hospital for Special Surgery guidelines, chronic opioid dependence (chronic daily opioid use for six or more months), and \< 60ml/min.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

GFR and eGFR (kidney filtering)

GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².

Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
312 participants (estimated)

Study arms

  • Experimental
    Complex Carbohydrate Drink Group

    The patients will drink a 400ml drink that contains 50g of complex carbohydrates, 3 hours prior to the surgery. The drink will be given once at the preoperative holding area. Patients are not allowed to eat solid foods after 12am the morning of surgery and can only drink clear fluids up to 3 hours prior to the surgery.

    Dietary Supplement: Complex Carbohydrate Drink

  • No intervention
    No-Complex Carbohydrate Drink Group

    These patients will follow normal institutional preoperative fluid management guidelines, this consist of no solid foods after 12am the morning of surgery. Patients are allowed to drink clear liquids (water, clear fruit juices, coffee) from 12am the morning of surgery up to 3 hours prior to the surgery.

Interventions

  • Dietary supplementComplex Carbohydrate Drink

    Patients will drink a complex carbohydrate drink 3 hours before surgery. Drink to be given at the preoperative holding area.

06

What researchers measure

Primary outcomes

  1. Length of hospital stay in hours

    Length of hospital stay in hours, assess by medical record.

    Time frame: From admission to discharge, up to 1 week

Secondary outcomes

  1. Same day discharge rate

    Percentage of patients discharged successfully the day of surgery.

    Time frame: Through study completion, an average of 3 months.

  2. Number of physical therapy sessions attempted

    Number of physical therapy sessions attempted, assess by medical record.

    Time frame: From admission to discharge, up to 1 week.

  3. Total distance walked

    Total distance walked during physical therapy attempts, assess by medical record.

    Time frame: From admission to discharge, up to 1 week.

  4. Number of stairs climbed

    Number of stairs climbed during physical therapy attempts, assess by medical record.

    Time frame: From admission to discharge, up to 1 week.

  5. Orthostatic hypotension episodes

    Orthostatic hypotension episodes during physical therapy attempts, assess by medical record.

    Time frame: During physical therapy attempts, from admission to discharge.

  6. HOOS JR Score

    This is a 6-item questionnaire that assesses patient-reported hip pain and function. Score ranges from 0-100, with 100 representing the best possible score.

    Time frame: The morning of surgery and at the first post-operative visit, up to 4 months post-op.

  7. KOOS JR Score

    This is a 6-item questionnaire that assesses patient reported knee pain and function. Score ranges from -100, with 100 representing the best score possible.

    Time frame: The morning of surgery and at the first post-operative visit, up to 4 months post-op.

  8. VR-12 Score

    The VR-12 is a 12-item self-reported questionnaire that assesses the patient physical and mental quality of life.

    Time frame: The morning of surgery and at the first post-operative visit, up to 4 months post-op.

  9. Urine osmolality

    Urine osmolality taken preoperatively, assess by medical record.

    Time frame: Measured preoperatively the morning of surgery.

  10. Urine specific gravity

    Urine specific gravity preoperatively, assess by medical record.

    Time frame: Measured preoperatively the morning of surgery.

  11. In-house costs

    In-house costs taking into account cost of complex carbohydrate drink vs previously published costs savings per night of stay.

    Time frame: From admission to discharge, up to 1 week.

07

Study locations

1 of 1 sites recruiting
  • Hospital for Special Surgery
    New York, New York 10021, United States
    Recruiting
    • Ricardo Torres, BS · Contacttorresr@hss.edu · 2122603763
    • Samuel Rodriguez, MD · Sub investigator
    • Alejandro Gonzalez Della Valle, MD · Sub investigator
    • Michael Ast, MD · Sub investigator
    • Stravos Memtsoudis, MD · Sub investigator
    • Ricardo Torres, BS · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05520593
Responsible party
Jose Rodriguez (Professor of Clinical Orthopaedic Surgery, Hospital for Special Surgery, New York) — Principal investigator
First posted
Aug 30, 2022
Start date
Nov 7, 2022
Primary completion
Jan 2027 (estimated)
Completion
Jan 2027 (estimated)
Last update
Apr 13, 2026

Study contacts

Jose Rodriguez, MD
Contact
rodriguezjose@hss.edu
212-552-5829
Ricardo Torres-Ramirez, BS
Contact
torresr@hss.edu
212-260-3763
Jose A Rodriguez, MD
principal investigator · Hospital for Special Surgery, New York

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion